Updated
Updated · Newsweek · Aug 15
Las Vegas Dad, 41, Joins Clinical Trial After Stage 4 Colon Cancer Defies 3 Chemotherapy Rounds
Updated
Updated · Newsweek · Aug 15

Las Vegas Dad, 41, Joins Clinical Trial After Stage 4 Colon Cancer Defies 3 Chemotherapy Rounds

1 articles · Updated · Newsweek · Aug 15

Summary

  • Kenny Berbick, a 41-year-old Las Vegas father, entered a clinical trial after three chemotherapy treatments stopped working against stage 4 colon cancer that had spread to his liver.
  • Years of intermittent warning signs — including blood in his stool, stomach pain, bowel changes, pencil-thin stools and weight loss — escalated until constant pain in 2025 pushed him to request a CT scan.
  • Doctors later called while he was picking up his daughter and told him to go to the emergency room immediately because the tumor was so large it could obstruct his colon.
  • Berbick, diagnosed at 40, now uses social media to urge people not to ignore symptoms and to get screened from age 45, saying he wants his story to save lives.
  • Colon cancer is the second-leading cause of U.S. cancer deaths for men and women combined, with more than 108,000 new cases and about 55,000 deaths estimated in 2026.

Insights

Why are seemingly healthy young adults suddenly falling victim to advanced colon cancer at unprecedented rates?
When traditional chemotherapy fails, what groundbreaking experimental treatments are keeping stage four cancer patients alive?
Could that easily dismissed stomach pain actually be a silent killer hiding in plain sight?